We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$640M
AUM Growth
+$42M
Cap. Flow
+$22.9M
Cap. Flow %
3.57%
Top 10 Hldgs %
39.6%
Holding
108
New
27
Increased
17
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$8.95M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.93M
3
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
+$7.92M
4
NVMI
Nova
NVMI
+$7.16M
5
TSEM icon
Tower Semiconductor
TSEM
+$6.92M

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$10.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.87M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$8.02M
4
LLY icon
Eli Lilly
LLY
+$6.71M
5
MSFT icon
Microsoft
MSFT
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 57.28%
2 Technology 9.65%
3 Consumer Discretionary 2.53%
4 Utilities 0.59%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.02T
$7.36M 1.15%
15,690
-16,000
-50% -$6.71M
MRUS
27
DELISTED
Merus
MRUS
$7.33M 1.14%
278,333
-58,660
-17% -$1.28M
MSFT icon
28
CALL
Microsoft
MSFT
$3.45T
$7.15M 1.12%
+21,000
New +$6.58M
IMTX icon
29
Immatics
IMTX
$1.18B
$7.12M 1.11%
617,173
-163,679
-21% -$1.53M
MLYS icon
30
Mineralys Therapeutics
MLYS
$2.25B
$6.91M 1.08%
405,400
+66,400
+20% +$992K
PANW icon
31
Palo Alto Networks
PANW
$270B
$6.9M 1.08%
54,000
+14,000
+35% +$1.46M
BIIB icon
32
Biogen
BIIB
$30B
$6.79M 1.06%
23,846
-9,670
-29% -$2.88M
CAMT icon
33
Camtek
CAMT
$6.18B
$6.75M 1.05%
189,494
-50,000
-21% -$1.43M
ENPH icon
34
CALL
Enphase Energy
ENPH
$4.96B
$6.7M 1.05%
+40,000
New +$7.15M
KURA icon
35
Kura Oncology
KURA
$800M
$6.38M 1%
603,287
– –
DAWN
36
DELISTED
Day One Biopharmaceuticals
DAWN
$6.33M 0.99%
+530,000
New +$6.92M
INZY
37
DELISTED
Inozyme Pharma
INZY
$6.31M 0.98%
1,131,967
-649,891
-36% -$3.84M
TSEM icon
38
Tower Semiconductor
TSEM
$24.8B
$6.28M 0.98%
+167,446
New +$6.92M
FUSN
39
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$6.21M 0.97%
1,329,258
+45,721
+4% +$198K
NVS icon
40
Novartis
NVS
$297B
$6.05M 0.95%
60,000
– –
SAGE
41
DELISTED
Sage Therapeutics
SAGE
$6.02M 0.94%
128,000
-27,000
-17% -$1.34M
JSPR icon
42
Jasper Therapeutics
JSPR
$21M
$5.86M 0.91%
427,401
+23,000
+6% +$342K
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$10.8B
$5.78M 0.9%
25,000
+6,000
+32% +$1.63M
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.57B
$5.73M 0.89%
50,000
+6,000
+14% +$774K
BBIO icon
45
BridgeBio Pharma
BBIO
$15.7B
$5.53M 0.86%
321,635
-240,348
-43% -$3.62M
CLDX icon
46
Celldex Therapeutics
CLDX
$2.99B
$5.43M 0.85%
+160,000
New +$5.39M
ISEE
47
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.29M 0.83%
134,414
-97,177
-42% -$3.43M
MORF
48
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5.16M 0.81%
+90,000
New +$4.7M
PFE icon
49
Pfizer
PFE
$143B
$5.14M 0.8%
140,000
– –
COGT icon
50
Cogent Biosciences
COGT
$6.65B
$4.97M 0.78%
420,000
+120,000
+40% +$1.38M
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sphera Funds Management held 108 positions worth $640M, up 7% from $598M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sphera Funds Management deployed $22.9M of net new capital in Q2 2023, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was Praxis Precision Medicines: 584,289 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $8.02M trimmed.

  • Sphera Funds Management's largest Q2 2023 buy was Praxis Precision Medicines: 584,289 shares worth $10.1M.
  • Sphera Funds Management added most to Amazon in Q2 2023, an estimated $4.41M increase.
  • Sphera Funds Management's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $8.02M.
  • Sphera Funds Management fully exited Nutrien in Q2 2023, selling an estimated $10.7M.
  • Sphera Funds Management's ten largest holdings make up 40% of its $640M portfolio in Q2 2023.
  • Sphera Funds Management opened 27 new positions and closed 21 in Q2 2023.
  • Sphera Funds Management's portfolio value rose 7% quarter-over-quarter to $640M.

Based on Sphera Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.